Chronic Lymphocytic Leukemia and Follicular Lymphoma | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia and Follicular Lymphoma - a podcast by Dr Neil Love
from 2021-08-02T12:00
::
::
Featuring perspectives from Dr Nathan H Fowler, Prof John G Gribben and Dr Brad S Kahl, including the following topics:
- Introduction (0:00)
- Choice of Front-Line Therapy for Chronic Lymphocytic Leukemia (CLL) (6:04)
- Selection of a BTK Inhibitor for the Treatment of CLL (20:11)
- Second-Line Therapy for CLL (27:50)
- Third-Line Therapy for CLL; Ongoing Research: Combination Strategies, Noncovalent BTK Inhibitors, CAR T-Cell Therapy (35:46)
- Selection of First- and Second-Line Treatment for Follicular Lymphoma (43:13)
- Third-Line Therapy for Follicular Lymphoma: Tazemetostat, PI3K Inhibitors, CAR T-Cell Therapy (49:33)
CME information and select publications
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love